Microcytic anemia: Pathology review

16,759views

test

00:00 / 00:00

Microcytic anemia: Pathology review

Step 1

Step 1

Tuberculosis: Pathology review
Obstructive lung diseases: Pathology review
Restrictive lung diseases: Pathology review
Apnea, hypoventilation and pulmonary hypertension: Pathology review
Lung cancer and mesothelioma: Pathology review
Deep vein thrombosis and pulmonary embolism: Pathology review
Pneumonia: Pathology review
Respiratory distress syndrome: Pathology review
Cystic fibrosis: Pathology review
Disorders of sex chromosomes: Pathology review
Prostate disorders and cancer: Pathology review
Testicular tumors: Pathology review
Uterine disorders: Pathology review
Ovarian cysts and tumors: Pathology review
Cervical cancer: Pathology review
Benign breast conditions: Pathology review
Complications during pregnancy: Pathology review
Congenital TORCH infections: Pathology review
Breast cancer: Pathology review
Vaginal and vulvar disorders: Pathology review
Androgens and antiandrogens
Adrenergic antagonists: Alpha blockers
PDE5 inhibitors
Estrogens and antiestrogens
Uterine stimulants and relaxants
Aromatase inhibitors
Progestins and antiprogestins
Congenital renal disorders: Pathology review
Renal tubular defects: Pathology review
Renal tubular acidosis: Pathology review
Acid-base disturbances: Pathology review
Electrolyte disturbances: Pathology review
Kidney stones: Pathology review
Renal and urinary tract masses: Pathology review
Osmotic diuretics
Loop diuretics
Potassium sparing diuretics
Carbonic anhydrase inhibitors
Thiazide and thiazide-like diuretics
ACE inhibitors, ARBs and direct renin inhibitors
Congenital neurological disorders: Pathology review
Headaches: Pathology review
Seizures: Pathology review
Cerebral vascular disease: Pathology review
Traumatic brain injury: Pathology review
Spinal cord disorders: Pathology review
Dementia: Pathology review
Central nervous system infections: Pathology review
Movement disorders: Pathology review
Demyelinating disorders: Pathology review
Adult brain tumors: Pathology review
Pediatric brain tumors: Pathology review
Neurocutaneous disorders: Pathology review
General anesthetics
Local anesthetics
Neuromuscular blockers
Back pain: Pathology review
Rheumatoid arthritis and osteoarthritis: Pathology review
Gout and pseudogout: Pathology review
Seronegative and septic arthritis: Pathology review
Systemic lupus erythematosus (SLE): Pathology review
Bone disorders: Pathology review
Bone tumors: Pathology review
Myalgias and myositis: Pathology review
Neuromuscular junction disorders: Pathology review
Pigmentation skin disorders: Pathology review
Acneiform skin disorders: Pathology review
Vesiculobullous and desquamating skin disorders: Pathology review
Papulosquamous and inflammatory skin disorders: Pathology review
Skin cancer: Pathology review
Immunodeficiencies: T-cell and B-cell disorders: Pathology review
Immunodeficiencies: Phagocyte and complement dysfunction: Pathology review
Immunodeficiencies: Combined T-cell and B-cell disorders: Pathology review
Microcytic anemia: Pathology review
Non-hemolytic normocytic anemia: Pathology review
Intrinsic hemolytic normocytic anemia: Pathology review
Extrinsic hemolytic normocytic anemia: Pathology review
Macrocytic anemia: Pathology review
Heme synthesis disorders: Pathology review
Mixed platelet and coagulation disorders: Pathology review
Leukemias: Pathology review
Myeloproliferative disorders: Pathology review
Anticoagulants: Heparin
Anticoagulants: Warfarin
Anticoagulants: Direct factor inhibitors
Antiplatelet medications
Congenital gastrointestinal disorders: Pathology review
Esophageal disorders: Pathology review
Inflammatory bowel disease: Pathology review
GERD, peptic ulcers, gastritis, and stomach cancer: Pathology review
Malabsorption syndromes: Pathology review
Diverticular disease: Pathology review
Gastrointestinal bleeding: Pathology review
Appendicitis: Pathology review
Colorectal polyps and cancer: Pathology review
Pancreatitis: Pathology review
Jaundice: Pathology review
Viral hepatitis: Pathology review
Cirrhosis: Pathology review
Eye conditions: Refractive errors, lens disorders and glaucoma: Pathology review
Eye conditions: Retinal disorders: Pathology review
Vertigo: Pathology review
Eye conditions: Inflammation, infections and trauma: Pathology review
Nasal, oral and pharyngeal diseases: Pathology review
Adrenal insufficiency: Pathology review
Adrenal masses: Pathology review
Hypothyroidism: Pathology review
Hyperthyroidism: Pathology review
Thyroid nodules and thyroid cancer: Pathology review
Parathyroid disorders and calcium imbalance: Pathology review
Cushing syndrome and Cushing disease: Pathology review
Diabetes mellitus: Pathology review
Pituitary tumors: Pathology review
Hypopituitarism: Pathology review
Multiple endocrine neoplasia: Pathology review
Diabetes insipidus and SIADH: Pathology review
Acyanotic congenital heart defects: Pathology review
Cyanotic congenital heart defects: Pathology review
Atherosclerosis and arteriosclerosis: Pathology review
Coronary artery disease: Pathology review
Peripheral artery disease: Pathology review
Valvular heart disease: Pathology review
Cardiomyopathies: Pathology review
Heart failure: Pathology review
Supraventricular arrhythmias: Pathology review
Aortic dissections and aneurysms: Pathology review
Pericardial disease: Pathology review
Endocarditis: Pathology review
Shock: Pathology review
Hypertension: Pathology review
Vasculitis: Pathology review
Cardiac and vascular tumors: Pathology review
Autosomal trisomies: Pathology review
Miscellaneous genetic disorders: Pathology review
Muscular dystrophies and mitochondrial myopathies: Pathology review
Purine and pyrimidine synthesis and metabolism disorders: Pathology review
Disorders of carbohydrate metabolism: Pathology review
Disorders of fatty acid metabolism: Pathology review
Glycogen storage disorders: Pathology review
Dyslipidemias: Pathology review
Lysosomal storage disorders: Pathology review
Fat-soluble vitamin deficiency and toxicity: Pathology review

Assessments

USMLE® Step 1 questions

0 / 8 complete

Questions

USMLE® Step 1 style questions USMLE

0 of 8 complete

A 2-year-old boy is brought to the clinician by his parents due to easy fatigability and growth delay. They recently immigrated to the United States. The mother did not receive any prenatal care in her home country. The child was born at term by a normal vaginal delivery. He is at the 30th percentile for length and below the 10th percentile for weight. Temperature is 37.2°C (98.9°F), pulse is 115/min, respirations are 25/min, and blood pressure is 85/60 mmHg. Abdominal examination shows hepatosplenomegaly. Hematological tests and hemoglobin electrophoresis are obtained:  
 
 Laboratory value  Result 
 Hemoglobin (Hb)  10.8 g/dL 
 Hematocrit (Hct 32% 
 Erythrocyte count  5.7 million/mm3 
 Hemoglobin A(HbA2)   6.5% 
 Fetal hemoglobin (HbF)  60% 
 Hemoglobin A (HbA1 None 
 Hemoglobin S (HbS None 

Which of the following is the most likely diagnosis? 

Transcript

Watch video only

At the family medicine center, there is a 60-year-old Indigenous American named Istu who came to visit the doctor because of his progressive fatigue and difficulty in swallowing. Next to him, there is a mother from Greece with her child, Thalia, who is 10 months old. Little Thalia appeared healthy at birth but in the past 2 months, her mother noticed that her face was often pale, she’s been less active, and there was a mass in her belly.

Both Istu and Thalia are suffering from anemia, which is defined as lower than average levels of hemoglobin, typically below 13.5 g/dL in adult men and below 12.0 g/dL in adult women. For children, this level varies based on the age. Now, anemias can be broadly grouped into 3 categories based on mean corpuscular volume, or MCV, which reflects the volume of a Red blood cell or RBC. So microcytic anemia is where the MCV is lower than 80 fL, normocytic, with an MCV between 80 and 100 fL, and macrocytic, with an MCV larger than 100 fL. Now, let’s focus on the microcytic anemias, and the most common causes are iron deficiency anemia, lead poisoning, sideroblastic anemia, and thalassemias. Although microcytic anemia can also present in anemia of chronic disease, which is caused by Inflammatory conditions like rheumatoid arthritis, and systemic lupus erythematosus or SLE, it’s usually classified as normocytic anemia.

Now iron deficiency anemia, lead poisoning, and sideroblastic anemia are caused by defective heme synthesis, while thalassemias are caused by defective globin chains. Normally, RBCs are loaded with millions of copies of a protein called hemoglobin. Hemoglobin is actually made up of four peptide, or globin, chains, each bound to a heme group. Those 4 heme molecules have, right in the middle, iron, which binds to oxygen and allows it to move in our body.

Okay, so let’s look at iron deficiency anemia which could be caused by decreased intake, decreased absorption, increased demand, or increased loss of iron. For your exams, it’s important to know that the clues to help you identify this disorder are often based on the patient’s history. A high yield fact is that the most common cause of iron deficiency is chronic blood loss. This includes women with heavy menstruation or people with bleeding gastric ulcers, and, most importantly, elderly males with colon cancer that can bleed.

Another cause of iron deficiency is decreased absorption. The duodenal cells are normally responsible for the absorption of iron which is present in two forms in our diet, the heme iron and the non-heme iron. The heme iron is in the ferrous, or Fe2+ state and can be directly absorbed, but the non-heme iron is in the ferric, or Fe3+, state, and needs to be reduced to heme iron first before being absorbed. So the stomach’s hydrochloric acid activates a group of enzymes in the duodenal cells, collectively called ferri-reductase, which reduce Fe3+ to Fe2+. Okay, so decreased iron absorption can occur with inflammation and destruction of duodenal cells like in inflammatory bowel disease or celiac disease, or with decreased stomach acid production, like after a gastrectomy, where a part of the stomach is removed.

Next, malnutrition which sometimes happens in infants and vegans, and increased iron demand, like during pregnancy, can also cause iron deficiency anemia.

So whatever the cause, we end up with a decrease in the body’s iron stores, leading to decreased heme synthesis and normally, there’s a low level of free erythrocyte protoporphyrin, or FEP, in red blood cells since this is a precursor to heme. So when there’s a defect in heme synthesis, these precursors build up and it’s a good indicator for iron deficiency. The peripheral blood smear shows RBCs that are microcytic, since there’s not enough hemoglobin for a normal sized RBC, and the bone marrow starts pumping out smaller cells. They are also hypochromic since they contain less hemoglobin and look more pale. Okay, another important fact is that the red blood cell distribution width, or RDW, is high. This is because we get a mix of normal sized cells from before the iron deficiency and newly produced microcytic cells.

Okay, moving on. If someone is chronically exposed to lead, usually children ingesting lead-containing paint chips or adults who inhale lead while working in mines or industry, they can get lead poisoning.

Lead inhibits δ-aminolevulenic acid, or δ-ALA, dehydratase, and ferrochelatase, two important enzymes in the heme synthesis pathway. It’s important to remember that lead also inhibits rRNA degradation, causing old rRNA to accumulate inside the RBCs, forming tiny aggregates that are dispersed throughout the cytoplasm and this is referred to as stippling. Once again, this affects heme synthesis, so free erythrocyte protoporphyrin, or FEP, builds up. On a peripheral blood smear, these aggregates stain blue, so they are basophilic, and we call this basophilic stippling. Now, just like iron deficiency anemia there’s a decrease in hemoglobin synthesis so we get microcytic and hypochromic RBCs. The RDW is high, because we also get a mix of normal sized cells produced before the lead poisoning and newly produced microcytic cells.

Next up is sideroblastic anemia, where sidero means iron, and refers to iron accumulation in the mitochondria, and blast refers to the nucleated precursors of RBCs called erythroblasts. Sideroblastic anemia can be genetic or acquired. X-linked defect in ALA synthase gene is a genetic cause. ALA synthase normally catalyzes the first reaction in the heme biosynthetic pathway, and a defect in this enzyme prevents iron from being incorporated into heme and they build up in the mitochondria. The acquired causes include pyridoxine or vitamin B6 deficiency, since ALA synthase uses vitamin B6 as a cofactor. For your exams, vitamin B6 deficiency commonly occurs as a result of isoniazid, which binds and inactivates vitamin B6.

Myelodysplastic syndrome is an acquired cause of sideroblastic anemia where the blood forming cells in the bone marrow do not mature normally and become dysplastic. It’s important to know that this increases the risk of developing hematological malignancies like acute myeloid leukemia. Other acquired causes include chronic alcohol use, lead poisoning, vitamin B6 deficiency, copper deficiency, and drugs like isoniazid, and chloramphenicol. Remember for your test that these are reversible causes.

On a peripheral blood smear, we get microcytic hypochromic RBCs and basophilic stippling, so it’s similar to lead poisoning. However, the specific test to use is the prussian blue stain on a bone marrow biopsy specimen, which shows the iron laden mitochondria forming a ring around the nucleus, giving the classic ringed sideroblast appearance. Finally, the RDW is high as we get a mix of normal sized cells and newly produced microcytic cells.

Okay, moving on to thalassemias, where there’s a deficiency or absence in the production of the globin chains of hemoglobin. Hemoglobin A, or HbA, made up of two α-globin and two β-globin peptide chains, makes up approximately 97% of the total hemoglobin in adults. Hemoglobin A2, or HbA2, which is made up of two α-globin and two δ-globin chains makes up approximately 2.5% of total hemoglobin. Now, hemoglobin F, or HbF, made up of two α-globin and two γ-globin peptide chains, is the primary hemoglobin of the fetus, but makes up less than 1% in adults. In alpha-thalassemia, there is a mutation in the genes that code for alpha globin chains, while in beta-thalassemia, there is a mutation in the genes that code for the beta globin chains.

Sources

  1. "Robbins Basic Pathology" Elsevier (2017)
  2. "Harrison's Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2)" McGraw-Hill Education / Medical (2018)
  3. "Goldman-Cecil Medicine" Saunders (2015)
  4. "Letter to the Editor: Correcting iron deficiency" Australian Prescriber (2017)
  5. "Alpha-thalassemia" Genetics in Medicine (2011)
  6. "Iron deficiency anaemia" Lancet (2016)
  7. "Lead screening and prevalence of blood lead levels in children aged 1-2 years--Child Blood Lead Surveillance System, United States, 2002-2010 and National Health and Nutrition Examination Survey, United States, 1999-2010" MMWR Suppl. (2014)
  8. "Sideroblastic anemia: diagnosis and management" Hematol Oncol Clin North Am. (2014)